George A. Scangos - Oct 23, 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Stock symbol
VIR
Transactions as of
Oct 23, 2024
Transactions value $
$0
Form type
4
Date filed
10/24/2024, 04:26 PM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 +598K +494.48% $0.00 719K Oct 23, 2024 Direct F1
transaction VIR Common Stock Other $0 -598K -34.19% $0.00 1.15M Oct 23, 2024 See footnote F1, F2
transaction VIR Common Stock Other $0 +598K $0.00 598K Oct 23, 2024 See footnote F1, F3
transaction VIR Common Stock Other $0 -598K -34.19% $0.00 1.15M Oct 23, 2024 See footnote F1, F4
holding VIR Common Stock 33.6K Oct 23, 2024 See footnote F5
holding VIR Common Stock 180K Oct 23, 2024 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer without consideration for tax planning purposes.
F2 The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
F3 The shares are held by the spouse of the reporting person.
F4 The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
F5 The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
F6 The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.